InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Patzer Eric, Director. Director active across 1 companies, notably Aridis Pharmaceuticals, Inc.. In total, 2 reports have been published. Total volume traded: €42k. The latest transaction was disclosed on 27 July 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€21,1855,175 shares@ €4.0937100.0% of flow
Common Stock
SEC:0001104659-21-096531·
Ideal exit: 23 Apr 2022 (T+270)
€21,1855,175 shares@ €4.09370.069% mcap50.0% of flow
Common Stock
SEC:0001104659-21-096531:0·
Ideal exit: 23 Apr 2022 (T+270)
2 of 2 declarations
About Patzer Eric
Eric Patzer serves as a Director at Aridis Pharmaceuticals, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Eric brings valuable experience in the pharmaceutical sector, enabling him to assess growth and innovation opportunities. His role is crucial in ensuring compliance and transparency in governance.
